Table 1. Clinicopathological Variables and BDNF expression in invasive front in 150 gastric cancer patients.
|
BDNF expression
|
||||
|---|---|---|---|---|
| Variable | n | High (n=68) | Low (n=82) | P |
|
Gender
| ||||
| Male | 119 | 52 | 67 | 0.431b |
| Female | 31 | 16 | 15 | |
|
Age (years)
| ||||
| <69 (median) | 71 | 42 | 37 | 0.042a,b |
| ⩾69 | 79 | 26 | 45 | |
|
Tumour size
| ||||
| ⩾5.5 cm (median) | 76 | 37 | 39 | 0.404 |
| <5.5 cm | 74 | 31 | 43 | |
|
Histological type
| ||||
| Intestinal type | 75 | 32 | 43 | 0.512b |
| Diffuse type | 75 | 36 | 39 | |
|
Pathological T category
| ||||
| pT1/2 | 52 | 19 | 33 | 0.115b |
| pT3/4 | 98 | 49 | 49 | |
|
Vessel involvement
| ||||
| + | 119 | 61 | 58 | 0.004a,b |
| − | 31 | 7 | 24 | |
|
Lymphatic vessel involvement
| ||||
| + | 138 | 65 | 73 | 0.140b |
| − | 12 | 3 | 9 | |
|
Lymph node metastasis
| ||||
| N0 | 45 | 13 | 32 | 0.008a,b |
| N1 | 105 | 55 | 50 | |
|
Liver metastasis
| ||||
| H0 | 138 | 63 | 75 | 0.790b |
| H1 | 12 | 4 | 8 | |
|
Peritoneal carcinomatosis
| ||||
| P0 | 123 | 51 | 72 | 0.042a,b |
| P1 | 27 | 17 | 10 | |
|
Stage classification
| ||||
| Stage I–II | 48 | 17 | 31 | 0.094b |
| Stage III–IV | 102 | 51 | 51 | |
P<0.05.
Pearson’s χ2-test.